Viewing Study NCT01994668


Ignite Creation Date: 2025-12-24 @ 5:53 PM
Ignite Modification Date: 2026-04-13 @ 6:46 AM
Study NCT ID: NCT01994668
Status: COMPLETED
Last Update Posted: 2014-03-03
First Post: 2013-11-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult Subjects
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module